Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Ginsburg, D.O.
Meda Pharma US
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mcs Clinical Trials
Los Angeles, California, United States
- Sunshine Research Center
Opa-locka, Florida, United States
- Altus Rsearch,inc
West Palm Beach, Florida, United States
- Provident Clincal Research
Addison, Illinois, United States
- Central Kentucky Research
Lexington, Kentucky, United States
- Rochester Clinical Research
Rochester, New York, United States
- Pgm Research of Winston-Salem, Llc
Winston-Salem, North Carolina, United States
- Clinical Partners Llc
Johnston, Rhode Island, United States
- Corsicana Medical Research,pnc
Corsicana, Texas, United States
- National Clinical Research-Richmond,inc.
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2012
- Primary completion
- 31 Dec 2012
- Completion
- 28 Feb 2013
- Last update posted
- 22 May 2014
- Registered enrollment
- 54
- Registry id
- NCT01574612
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.